Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Insulin symbols : NVO save search
Awiqli® (once-weekly basal insulin icodec) recommended for approval for the treatment of diabetes by the European regulatory authorities
Published: 2024-03-21 (Crawled : 16:00) - globenewswire.com
NVO | News | $123.37 -0.93% 1.4M
|
Health Technology
|
| O: -1.04%
H: 1.6%
C: 0.64%
awiqli approval treatment diabetes insulin
Insulin Pen Global Market Outlook Report 2024-2028: Current Market Size and Revenue Growth Prospects for Insulin Pens, with Market Share Analysis by Type, Onset Time, End User and Geographical Region
Published: 2024-02-23 (Crawled : 17:00) - prnewswire.com
NVSEF | News | $93.6375 6.88% 82K
|
Health Technology
|
| O: 0.37%
H: 0.58%
C: 0.58%
VTRS | $11.12 0.18% 1.1M
|
Health Technology
|
| O: 0.0%
H: 1.93%
C: 1.27%
NVO | News | $123.37 -0.93% 1.4M
|
Health Technology
|
| O: -0.68%
H: 0.4%
C: -0.18%
NVS | News | $92.61 -0.51% 430K
|
Health Technology
|
| O: 0.89%
H: 0.4%
C: 0.17%
JNJ | News | $144.86 0.06% 2.8M
|
Health Technology
|
| O: 0.28%
H: 0.0%
C: 0.0%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 0.97%
H: 0.0%
C: 0.0%
report revenue global insulin growth market
COMBINE 3 phase 3a trial successfully completed with once-weekly IcoSema demonstrating non-inferior reduction in HbA1c versus daily basal-bolus treatment (insulin glargine U100 and insulin aspart) in people with type 2 diabetes
Published: 2024-01-08 (Crawled : 13:00) - globenewswire.com
NVO | News | $123.37 -0.93% 1.4M
|
Health Technology
|
| O: 0.19%
H: 0.34%
C: 0.21%
treatment glargine trial diabetes insulin
Aspen announces contract manufacturing agreement to initiate local production of Human Insulin for Novo Nordisk at its Gqeberha based sterile manufacturing facility
Published: 2023-09-19 (Crawled : 17:00) - aspenpharma.com
NVO | News | $123.37 -0.93% 1.4M
|
Health Technology
|
| O: -0.56%
H: 1.1%
C: 0.8%
contract agreement insulin
Global Insulin Pen Market Projected to Reach $73.39 Billion by 2028 with Steady CAGR of 5.25% during 2023-2028
Published: 2023-07-28 (Crawled : 19:00) - prnewswire.com
TRUMY | $16.69 54K
|
Manufacturing
| Email alert
Add to watchlist
NVO | News | $123.37 -0.93% 1.4M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 1.4K
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $749.245 -0.2% 550K
|
Health Technology
| Email alert
Add to watchlist
TRUMF | $17.112 1.5K
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
| Email alert
Add to watchlist
reach global insulin market
New data show once-weekly insulin icodec met additional endpoints in adults with type 2 diabetes in phase 3a trials
Published: 2023-06-24 (Crawled : 00:20) - prnewswire.com
NVO | News | $123.37 -0.93% 1.4M
|
Health Technology
| Email alert
Add to watchlist
trials diabetes insulin show
Novo Nordisk A/S: New data show once-weekly insulin icodec met additional endpoints in adults with type 2 diabetes in phase 3a trials
Published: 2023-06-24 (Crawled : 00:20) - globenewswire.com
NVO | News | $123.37 -0.93% 1.4M
|
Health Technology
| Email alert
Add to watchlist
trials diabetes insulin show
Beta Bionics Announces FDA Clearance for the Use of a Prefilled Insulin Cartridge With the iLet Bionic Pancreas
Published: 2023-06-22 (Crawled : 14:00) - biospace.com/
NVO | News | $123.37 -0.93% 1.4M
|
Health Technology
|
| O: -0.45%
H: 0.89%
C: 0.13%
fda pancreas clearance insulin
USD 5.81 Billion Growth in Insulin Biosimilars Market Size - Industry Analysis, Market Trends, Market Growth, Opportunities
Published: 2023-04-28 (Crawled : 15:20) - prnewswire.com
NVO | News | $123.37 -0.93% 1.4M
|
Health Technology
|
| O: 0.22%
H: 1.02%
C: 0.42%
insulin growth market
Novo Nordisk to lower U.S. prices of several pre-filled insulin pens and vials up to 75% for people living with diabetes in January 2024
Published: 2023-03-14 (Crawled : 19:00) - biospace.com/
NVO | News | $123.37 -0.93% 1.4M
|
Health Technology
|
| O: 1.15%
H: 0.65%
C: 0.56%
diabetes living insulin
Insulin Pump Market - Global Outlook and Forecast 2023-2028: New Product Launches and Technological Advances in Diabetes Care Present Opportunities
Published: 2023-03-04 (Crawled : 04:20) - prnewswire.com
PODD | $169.175 1.75% 150K
|
Health Technology
| Email alert
Add to watchlist
NVO | News | $123.37 -0.93% 1.4M
|
Health Technology
| Email alert
Add to watchlist
care global diabetes insulin market
Smart Insulin Pens Market Size to Reach USD 302.1 Million in 2030 | Emergen Research
Published: 2023-02-06 (Crawled : 18:00) - prnewswire.com
NVO | News | $123.37 -0.93% 1.4M
|
Health Technology
|
| O: 0.61%
H: 0.88%
C: 0.33%
MDT | News | $78.7 -0.48% 1.7M
|
Health Technology
|
| O: -0.31%
H: 0.08%
C: -1.83%
LLY | News | $749.245 -0.2% 550K
|
Health Technology
|
| O: 0.86%
H: 0.42%
C: -1.26%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: 0.0%
research smart insulin market
LANNETT PROVIDES DEVELOPMENT UPDATE ON BIOSIMILAR INSULIN PRODUCTS
Published: 2023-01-04 (Crawled : 12:00) - prnewswire.com
NVO | News | $123.37 -0.93% 1.4M
|
Health Technology
|
| O: 1.24%
H: 0.01%
C: -1.36%
biosimilar update insulin
Global Insulin Pen Market Analysis & Forecasts, 2021-2022 & 2023-2027: Focus on United States, India, China, Brazil, Saudi Arabia, United Kingdom, Germany, Netherlands, Sweden, Switzerland, Australia
Published: 2022-12-22 (Crawled : 20:00) - prnewswire.com
TRUMF | $17.112 1.5K
|
Health Technology
|
| O: 3.99%
H: 0.0%
C: -0.64%
TRUMY | $16.69 54K
|
Manufacturing
|
| O: -1.16%
H: 2.28%
C: 1.1%
NVO | News | $123.37 -0.93% 1.4M
|
Health Technology
|
| O: -0.04%
H: 0.33%
C: 0.33%
LLY | News | $749.245 -0.2% 550K
|
Health Technology
|
| O: -0.13%
H: 0.84%
C: 0.84%
global australia insulin market
Human Insulin Market is expected to generate a revenue of USD 63.64 Billion by 2028, Globally, at 7.65% CAGR: Verified Market Research®
Published: 2022-11-15 (Crawled : 17:00) - prnewswire.com
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: 0.0%
NVO | News | $123.37 -0.93% 1.4M
|
Health Technology
|
| O: -0.59%
H: 0.37%
C: -0.1%
LLY | News | $749.245 -0.2% 550K
|
Health Technology
|
| O: 0.25%
H: 0.01%
C: -1.96%
BDX | $230.84 -0.59% 300K
|
Health Technology
|
| O: 0.92%
H: 0.0%
C: -1.71%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 1.37%
H: 0.0%
C: 0.0%
research expected insulin market
Insulin Market is Likely to Upsurge USD 25.12 Billion Globally by 2029, Size, Share, Trends, Demand, Market Dynamics, Growth Forecast and Challenges
Published: 2022-11-07 (Crawled : 10:00) - prnewswire.com
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: -2.01%
H: 0.88%
C: 0.88%
NVO | News | $123.37 -0.93% 1.4M
|
Health Technology
|
| O: 0.91%
H: 1.82%
C: 1.43%
LLY | News | $749.245 -0.2% 550K
|
Health Technology
|
| O: 0.17%
H: 2.51%
C: 1.97%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: -0.46%
H: 0.0%
C: 0.0%
insulin growth market
Global Insulin Delivery Devices Market Report 2022-2030: Growing Diabetic Population & Surge in the Launch of Insulin Delivery Devices
Published: 2022-10-17 (Crawled : 16:00) - prnewswire.com
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 0.67%
H: 0.0%
C: 0.0%
NVO | News | $123.37 -0.93% 1.4M
|
Health Technology
|
| O: 1.18%
H: 1.26%
C: 0.93%
MDT | News | $78.7 -0.48% 1.7M
|
Health Technology
|
| O: 1.46%
H: 0.94%
C: -0.05%
LLY | News | $749.245 -0.2% 550K
|
Health Technology
|
| O: 0.42%
H: 1.44%
C: -0.01%
BDX | $230.84 -0.59% 300K
|
Health Technology
|
| O: 0.74%
H: 1.69%
C: 1.18%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 0.51%
H: 0.95%
C: 0.65%
PODD | $169.175 1.75% 150K
|
Health Technology
|
| O: -0.52%
H: 4.35%
C: 1.9%
global report growing insulin market diabetic
Oral Biologics & Biosimilars Global Market Report 2022: Drive to Create Insulin Biosimilars Presents Opportunities
Published: 2022-10-14 (Crawled : 12:00) - prnewswire.com
SNYNF | News | $92.7 1.4K
|
Health Technology
|
| O: 6.95%
H: 0.0%
C: 0.0%
AZNCF | $140.15 560
|
Health Technology
|
| O: 1.95%
H: 1.5%
C: 1.5%
NVO | News | $123.37 -0.93% 1.4M
|
Health Technology
|
| O: 0.03%
H: 0.35%
C: -1.01%
GSK | $39.44 -0.4% 560K
|
Health Technology
|
| O: 0.59%
H: 0.66%
C: -0.39%
SNY | News | $45.445 -1.44% 2.6M
|
Health Technology
|
| O: 2.74%
H: 0.0%
C: 0.0%
ENTX | $2.26 1.8% 130K
|
Health Technology
|
| O: 1.06%
H: 0.01%
C: -4.53%
AZN | $68.635 0.15% 1.3M
|
Health Technology
|
| O: 1.22%
H: 0.52%
C: -2.21%
RVP P | $1.04 14K
|
Health Technology
|
| O: -1.55%
H: 8.42%
C: 5.26%
global report insulin market
Once-weekly insulin icodec demonstrates superior reduction in HbA1c in combination with a dosing guide app versus once-daily basal insulin in people with type 2 diabetes in ONWARDS 5 phase 3a trial
Published: 2022-10-03 (Crawled : 12:20) - globenewswire.com
NVO | News | $123.37 -0.93% 1.4M
|
Health Technology
|
| O: 1.98%
H: 1.29%
C: 0.94%
trial diabetes insulin
More people with type 2 diabetes achieved blood sugar target with once-weekly insulin icodec compared with once-daily insulin degludec
Published: 2022-09-22 (Crawled : 07:00) - globenewswire.com
NVO | News | $123.37 -0.93% 1.4M
|
Health Technology
|
| O: -0.44%
H: 0.38%
C: -0.48%
blood diabetes insulin
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
AGBA | $1.05 162.5% 100M
|
Finance
INVO | $1.36 78.95% 3.6M
|
Health Technology
BPTH | $5.62 73.46% 75M
|
Health Technology
TIRX | $0.8231 69.78% 54M
|
ISPC | $0.307 44.13% 3.6M
|
Professional, Scientific, and T...
SINT | $0.0519 39.14% 350M
|
Health Technology
XPON | $2.63 36.27% 8.4M
|
ALRN | $5.53 30.12% 250K
|
Health Technology
VTNR S | $1.26 28.68% 9.1M
|
Industrial Services
HOLO | $2.86 27.68% 28M
|
Your saved searches
Save your searches and get alerts when important news are released.